Sex disparities in hepatocellular carcinoma immunotherapy: hormonal and genetic influences on treatment efficacy
Hepatocellular carcinoma (HCC) is a highly aggressive liver cancer with a rising incidence globally. Immunotherapy, particularly immune checkpoint inhibitors (ICIs), has revolutionized HCC treatment, yet response rates remain variable. Sex-based disparities in immunotherapy efficacy have become incr...
Saved in:
| Main Authors: | Lei Song, Liyan Sun, Yuning Ren, Xiaodan Wang, Lei Xian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1607374/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disparities in Immunotherapy Use Prior to First-Line Approval for Metastatic Hepatocellular Carcinoma in the United States
by: Manav Shah, et al.
Published: (2025-02-01) -
Epigenetic remodeling by sex hormone receptors and implications for gender affirming hormone therapy
by: Den Celestra, et al.
Published: (2025-05-01) -
The roles of sex hormones in the pathophysiology of age‐related sarcopenia and frailty
by: Tatsuya Hosoi, et al.
Published: (2024-01-01) -
Sex hormones and allergies: exploring the gender differences in immune responses
by: Jesús Alberto Gutiérrez-Brito, et al.
Published: (2025-01-01) -
Sex hormones and immune regulation in ovarian cancer
by: Rui Zhao, et al.
Published: (2024-12-01)